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Abstract. In this paper, we utilize next-generation sequencing (NGS)
data from the LungMap project [1] to identify and characterize the devel-
opmental RNA transcriptome in alveolar epithelial type II (AT2) cells of
embryonic mouse lungs of gestational ages embryonic days 16 (E16) and
18 (E18). Late gestation lung cellular maturation is necessary for sur-
vival at birth [4]. Using R and the BioConductor packages for RNAseq
analysis, we analyze changes in the mouse lung AT2 cell RNA transcrip-
tome as this maturation process takes place. We particularly identify the
cluster of genes whose expression changes markedly between immature
(E16) and mature (E18) lungs which can be used to define cell pathways
that appear critical for the maturation process. Our results show that
there are 98 differentially expressed genes with 82 genes where differences
in counts cannot be attributed to difference in sample origin. We were
surprised to identify substantial differences in RNA expression between
two experienced lab groups that use identical protocols.
1 Introduction
Preterm birth, defined as birth before 37 weeks gestational age, is the leading
cause of death in the first year of life, and the major cause of death or chronic
morbidity following birth [8]. The primary basis of morbidity and mortality fol-
lowing preterm birth is the Respiratory Distress Syndrome (RDS), a common
breathing disorder that affects premature newborns shortly after birth. RDS is
generally caused by a lack of sufficient amounts of pulmonary surfactant in the
distal structures of the lung where gas exchange occurs to transfer oxygen into
the blood and remove carbon dioxide. Pulmonary surfactant is a complex mix-
ture of specific phospholipids and proteins that is required to keep the lungs fully
expanded at the end of each breath, thus allowing easy, effortless breathing. Its
main function is to reduce the surface tension that develops with each expiration
at the air/liquid interface in the lung produced by the small amounts of water
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that are present in the lung. Without surfactant the surface tension forces cause
progressive atelectasis, a collapse of the saccules and alveoli, which are the site
of gas exchange, and thus progressively inadequate oxygen intake and carbon
dioxide removal.
Most infants with RDS are those born before 32 weeks gestation since mat-
uration of the lung’s ability to synthesize surfactant takes place at 32-34 weeks.
Surfactant is synthesized in specialized cells in the saccules and alveoli called
Type II epithelial cells (AT2 cells). It is known that AT2 cell maturation is criti-
cal for surfactant production but the specific mechanisms controlling type II cell
maturation are incompletely defined [4].
In this study we are working to advance the understanding of fetal lung
maturation and AT2 cell development. The Lung Map Consortium is a multi-
institutional group of lung developmental biology investigators funded by the
Lung Division of the National Heart, Lung and Blood Institute at the National
Institutes of Health that collects, annotates, validates, and stores databases of
gene expression, protein expression, metabolite expression and structural im-
agery of the developing human and mouse lungs for use by interested inves-
tigators as source data for lung biology investigations. We utilize Lung Map
repository data to identify developmental patterns of AT2 cell gene expression
surrounding the timing of lung maturation in the embryonic mouse. Specifically,
we make use of Lung Map RNAseq data sets obtained from mouse lungs AT2
cells at embryonic days 16 (E16) and 18 (E18) of mouse gestation. These ges-
tational ages bracket the time at which surfactant synthesis normally surges in
the fetal mouse. We use R, in particular the Bioconductor suite of R packages
designed for RNAseq analysis [6, 7, 10, 11], to identify the developmental RNA
expression signatures at these two developmental ages. We further define how
the signatures change, with attention to relative changes between the two gesta-
tions in the expression of each gene in the mouse transcriptome. Strong changes
in expression are particularly noted for further analysis.
We expect the result of these studies to identify groups of genes whose expres-
sion falls or rises with progressing development in patterns that support and ex-
tend the knowledge of the regulation of the development of surfactant synthesis.
We expect that with this information future studies utilizing pathway analysis
will be able to categorize differentially regulated genes according to cellular pro-
cesses involved in the development of mature AT2 function. The outcome of this
project will be novel insight and understanding of fetal lung maturation, that
become a basis for new innovative studies of the developmental control of fetal
maturation, with the goal of identifying new therapeutic targets for preventing
and treating RDS and its complications.
2 Data
Three data sets, each consisting of RNAseq data from a set of experiments
utilizing male and female lungs from E16.5 and E18.5 days of gestations, as well
as various postnatal days, were used. The lungs were obtained by investigators
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within the LungMap Consortium, and prepared for RNA sequencing. Sequencing
was performed using a HiSeq 2500 System (Illumina, San Diego, CA). Overall,
among the three data sets, 30 female and 20 male samples were sequenced.
The experiments used mice from the inbred laboratory strain C57Bl6, a com-
monly used laboratory mouse strain widely available. Pregnancies were timed
based on the appearance of a vaginal plug the morning after breeding; this was
designated day E0.5. On day E16.5 or E18.5 the pregnant females were sacri-
ficed by CO2 inhalation, individual fetuses obtained and weighed, and the lungs
removed under sterile conditions. For preparations of sex-specific samples the
lungs were kept separate, otherwise the lungs were pooled. Fetal sex was subse-
quently identified by genotyping for the presence or absence of the Y chromo-
some. The lungs were prepared for RNA sequencing by cell dispersion and the
alveolar epithelial cell population isolated by cell sorting. cDNA libraries were
prepared and used to construct RNAseq libraries using TruSeq DNA Exome
library preparation and exome enrichment reagents (Illumina, San Diego CA).
RNA sequencing was performed as described by Treutlein, et al [13] using an
Illumina HiSeq 2500 sequencing platform. Sequencing was done on 100bp paired
end to a depth of 2-5 million reads. Raw data were output to *.fastq files, then
pre-processed and sequence alignment performed, then stored in compressed, Bi-
nary Sequence Alignment/Map (BAM) formatted data (.BAM) files which were
archived on the LungMap repository server.
The sequencing data used in this study were from 2 separate sequencing
experiments; the data files are identified on LungMap as LMEX0000001630,
hereafter referred to as data set 1630, and LMEX0000000684, hereafter referred
to as data set 684. The cell preparations, sequencing, and pre-processing were
done at two different institutional members of the LungMap consortium. Data set
1630 consisted of one replicate each of male and female lungs, each of gestational
age E16.5 and E18.5. Data set 684 contained data from two replicates each at
gestational ages E16.5 and E18.5, all from pooled-sex samples. The attributes of
data sets 684 and 1630 are presented in Table 1.
Table 1. Attributes of data sets 684 and 1630. File origin is either University of
Alabama (UAB) or Cincinnati Children’s Hospital Medical Center (CCHMC). Sex is
either Female (F), Male (M) or Both (B).
File ID Data Set Library Size Gestation Age File Origin Sex
1 684 26945282 E16.5 CCHMC B
2 684 21750402 E16.5 CCHMC B
3 684 25986466 E18.5 CCHMC B
4 684 25112237 E18.5 CCHMC B
5 1630 12271916 E16.5 UAB F
6 1630 15153460 E16.5 UAB M
7 1630 15329422 E18.5 UAB F
8 1630 13570271 E18.5 UAB M
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3 Differential expression analysis workflow
The goals of this analysis are to identify the transcriptomic signatures in AT2
cells isolated from E16 and E18 male and female mice, and begin to compare
those signatures over time to identify groups of genes that are differentially
expressed as AT2 maturation occurs.
Because the analysis uses counts of short sequences of nucleotides the prop-
erties of count data must be identified before doing statistical analysis. A major
property to evaluate is the possible sources of variability. Three sources of vari-
ability were considered: Poisson variability, biological variability and systematic
variability. The analysis seeks to identify systematic variability due to the dif-
ference between conditions after the other two sources have been controlled for.
Biological variability arises from inherent differences between individuals in ex-
pression levels. Large differences in the genetic code of specific genes are also
possible contributors to biologic variability, but this is unlikely within a popula-
tion from an inbred strain of mice. Poisson variability arises from the fact that
RNA is normally created from DNA in fragments of any individual gene, and in
the sequencing process each RNA fragment that is present either is or is not cap-
tured. Correct analysis and interpretation of the data requires the assumption
that all three sources of variability are present in the data. Another important
aspect of data analysis is that while genes are not expressed independently of
each other, the analysis makes comparisons one gene at a time, thus correction
for multiple comparisons must be done. The pipeline used to analyze the data
accounts and adjusts for all of these properties and is displayed in Figure 1.
Our analysis starts with the RSamtools package shown at the beginning of
the pipeline. This tool makes it possible to read compressed, Binary Sequence
Alignment/Map (BAM) formated data, a format that is frequently used to to
store and share genetic sequencing data. RSamtools transforms BAM files into a
format that can be understood by the downstream packages. The raw sequence
data contained in the BAM files were mapped to a reference mouse genome
database mm10, from the University of California Santa Cruz Genomics Institute
Genome Browser (https://genome.ucsc.edu/cgi-bin/hgGateway).
3.1 Feature counts and data normalization
Sequencing output provides raw counts. It is important to not use raw counts for
differential expression and related analyses since the depth of sequencing results
in libraries with higher counts. Therefore, raw counts were transformed into a
log2- counts per million (1CPM) scale that helps to normalize for library size
differences. After transformation to 1CPM, genes that showed extremely low
expression were removed, since genes that are not expressed or expressed at a
low level add distributional bias without providing any additional information to
the results. Removing these genes also has the advantage of reducing the overall
number of statistical tests that should be performed. Figure 2 shows the density
function of the 1CPM counts for raw and filtered data.
4















Fig. 1. In this work we use sequential process that consist of 4 steps: data transforma-
tion, mapping to reference genome, normalization, and differential expression analysis.
Fig. 2. The density function of the 1CPM counts of raw and filtered data. Left-hand
side shows density of 1CPM counts before filtering while right-hand side shows the
same data where genes with low expression are removed.
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The feature counts were normalized using the method of Trimmed Mean of
M-values [12] (TMM). The choice of normalization method has great impact
on results and is crucial for correct analysis of RNAseq data [2]. The numerical
value of genes can vary due to biological and technical variability. Normalization
helps to correctly infer differential signals in RNAseq data and to remove the
distributional influence of external factors that are not of biological interest. The
TMM method works under the assumption that the majority of genes are not
differentially expressed. It finds non-differentially expressed genes that have the
same level of expression and uses these genes to calculate normalization factors
that are applied to each sample to correct for non-biological variability. Factors
are calculated using adjusted mean, a method of averaging that removes a small
designated percentage of the largest and smallest values before calculating the
mean. Figure 3 illustrates the results of the data normalization.
Fig. 3. Unnormalized vs Normalized 1CPM data. Left-hand side show data before
applying Trimmed Mean of M-values (TMM) normalization method while right-hand
side shows the same data after transformation using TMM method.
For differential expression analysis we use a linear model that assumes con-
stant variance. Our data is discrete and violates this assumption since counts
have unequal variabilities even after log-transformation. For example, on the left-
hand side of Figure 4 there is a decreasing mean-variance trend for larger counts.
To accommodate mean-variance relationship we estimate it from the data us-
ing robust method proposed by Law et al. [5]. To adjust for heteroscedasticity
the method estimates the mean-variance trend non-parametrically and uses this
relationship to predict the variance of each observation. Next it uses predicted
variance to assign a weight to each observation. The weights are then used in
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the linear modeling process. The right-hand side of Figure 4 illustrates the effect
of adjusting the relationship of the means and the variances.
Fig. 4. Mean-variance trend before and after transformation. Each black dot represents
a gene. On the left side gene-wise square-root residual variances extracted from fitting
linear models to data are plotted against 1CPM counts. Red line follows estimated
mean-variance trend. Right-hand side displays log2 residual standard deviations against
mean 1CPM values.
Table 2. Design matrix. The matrix is set up to compare gestation ages (E16.5 vs
E18.5), origin (CCHMC vs UAB) and interaction of origin and gestation age.
E16.5 E18.5 UAB E18.5 x UAB
1 0 0 0
1 0 0 0
0 1 0 0
0 1 0 0
1 0 1 0
1 0 1 0
0 1 1 1
0 1 1 1
7
Nielsen et al.: The Transcript Profile Changes With Developmental Maturation of Fetal Lung Type 2 Cells: An Analysis of RNAseq Data
Published by SMU Scholar, 2020
3.2 Linear Models, the Design Matrix, and the Contrast Matrix
To model the expression of each gene we use linear combination of different
explanatory factors
E(yg) = Xβg + εg
where yg is a response vector yg1, ..., ygn for the gth gene, X is a design matrix
representing the experimental design and βg is an unknown coefficient vector
that parametrizes the average expression levels in each experimental condition.
For each gene, the ygi are assumed independent. We find an estimate for βg using
β̂ = (XTWgX)
−1XTWgyg





where σg is an unknown standard deviation and the wgi are known weights. The
sample variance for each gene is assumed to follow a scaled χ2d distribution with





The unknown residual variances are allowed to vary across genes by assuming
scaled inverse χ2d prior distribution. The posterior variance is a combination of








where d0 and dg are prior and empirical degrees of freedom, respectively. This
way including a prior distribution of variances has the effect of borrowing in-
formation from all genes to aid with inference about individual genes. The T-






where vi is the i diagonal element of (X
TWgX)
−1
This model is described by Phipson et al. [9] and is implemented in limma [10]
package, that was initially designed for analysis of data from experiments involv-
ing microarrays but was later extended and can be used for RNA-seq data as
well.
In our analysis, we fit linear models to see which genes are expressed at dif-
ferent levels between different gestational ages and sample origins. Our design
matrix is set up to help us uncover these differences as well as interactions be-
tween sample origin and gestational age. The table 2 summarizes our design
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matrix. For pairwise comparisons we set up 3 contrasts: E16.5 vs E18.5 to com-
pare gene expression at different gestational ages, UAB vs CCHMC to see how
sample origin affects gene expression and E18.5 (origin UAB) vs E18 (origin
CCHMC) to see whether there is any interaction between sample’s origin and
gestational age.
4 Ethical Considerations
Throughout the research and data analysis it is important to reflect on the ethical
considerations for all involved. It is easy to feel removed from ethical concerns
when examining data retrieved from third party repositories, collected by unseen
researchers. This is exactly why it is imperative to refrain from simply exploring
the dataset without questioning the background of how the data was collected.
Understanding these processes and procedures helps ensure the collection was
completed in an ethical fashion as well as assures the information gained from
the analysis will be applicable to the general population.
Research involving medical experimentation requires meticulous attention to
ethical concerns. Addressing those concerns often begins at the design stage of
an experiment [3]. It is important to confirm individuals involved in the research
experiments were treated with respect and dignity. When animals are utilized
in medical research it is necessary to handle them as humanely as possible while
also respecting the requirements of the experiment. Mice are largely utilized in
medical studies for a multitude of reasons. Mice are small, inexpensive to obtain
and care for, and reproduce quickly which allows for several generations to be
studied at an expressed rate. They are also available in large quantities and
can be obtained from commercial producers which breed them specifically for
research purposes.
The objective of this study was to identify and characterize the developmen-
tal RNA transcriptome in alveolar epithelial type II cells of embryonic mouse
lungs. The experiments used mice from the inbred laboratory strain C57Bl6.
Using inbred mice lets researchers control for possible genetic variation which
in turn allows the ability to have smaller test groups and leads to less mice be-
ing sacrificed. Mice are frequently used to model the biology of the human lung
development as the developmental events, molecules and structures are closely
similar. The results of this project are buttressed by a large body of biochem-
ical data that allow straightforward comparisons and insight into human lung
biology.
Pregnant females were sacrificed by CO2 inhalation, individual fetuses ob-
tained and weighed, and the lungs removed under sterile conditions. The use of
CO2 inhalation is one of the humane methods used to sacrifice animals used in
medical experiments.
The ability to conduct this type of study with humans is difficult and rare.
Although there is a possibility for a human subject of these gestational periods
to be donated, the sample size would be extremely small. Therefore, generalizing
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results to a population would not be possible. Using mice data is the most ethical
possibility while still having the ability to generalize to human populations.
5 Results
To show similarities and dissimilarities between samples we used an unsupervised
clustering method that is based on Principal Component Analysis (PCA). Figure
5 shows that samples cluster well within gestation age, our primary condition of
interest. On the other hand sample origin also can be used to separate samples
into two distinct groups. This result tells us that there is significant difference
between CCHMC and UAB samples. Sex cannot be separated using any principal
component.
Our model used for differential expression analysis identified 98 differentially
expressed (DE) genes between E16.5 and E18.5. Of these, 50 genes were down-
regulated and 48 genes were up-regulated. A mean-difference plot summarizing
the DE analysis is shown in Figure 6. Figure 7 shows the number and distribution
of DE genes for UAB vs CCHMC. We were surprised to find 644 up regulated and
617 down regulated DE genes when comparing samples coming from different
labs. We found no genes affected by interaction of sample origin and gestational
age. While most of the DE genes we found are due to difference in sample origin
we found 82 genes that were different due to biological reasons, as can be seen
in Figure 8 and table 3
Table 3. The top DE genes that were different due to biological reasons when com-
paring E16.5 and E18.5.
Entrezid Symbol Chromosome PValue
12654 Chil1 chr1 0.00001813
12266 C3 chr17 0.00008442
17110 Lyz1 chr10 0.00014304
20390 Sftpd chr14 0.00032068
71584 Gdpd2 chrX 0.00061442
72432 Spink5 chr18 0.00071023
17105 Lyz2 chr10 0.00073025
22361 Vnn1 chr10 0.00082452
170799 Rtkn2 chr10 0.00132963
16592 Fabp5 chr3 0.00132963
6 Discussion
A major advancement in molecular biology has been the development of RNA
sequencing to parallel earlier advancements in DNA sequencing. The technol-
ogy for creating libraries of RNA sequence data from an entire transcriptome
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offers the opportunity to develop new understandings of biological processes at a
more complete scale. This technological advancement has required simultaneous
advancements in the capability to analyze and interpret such data. The data
science capabilities for data analysis have kept apace with the developing RNA
sequencing field as larger and more complex data sets are generated. In this
study we have leveraged data analytical capabilities to create new insight into
the development of the lung in preparation for survival after birth.
When a child is born many physiologic systems must undertake functions
that they have not yet needed to perform. Healthy survival at birth is dependent
on the immediate and successful implementation of some of those functions, for
Fig. 5. Similarities and dissimilarities between samples using PCA. On the top-left
there is a visible separation between sample origin using first principal component. Top-
right plot shows that gestation age can be separated using second principal component.
Bottom-right plot shows that there is no visible separation between different sex values.
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others the successful implementation can be brought online over a period of days
to months. One of the necessary immediate implementations is the ability of the
lungs to provide oxygen and remove carbon dioxide via gas exchange mechanisms
in the saccular and alveolar structures. These structures are lined by two types
Fig. 6. Mean-difference plot summarizing DE analysis of E18 vs E16 groups which
display log-FCs from the linear model fit against the average 1CPM values. Each gene
is represented by a black dot. Red dots are up-regulated while down-regulated genes
are shown as blue dots.
Fig. 7. Mean-difference plot displaying DE analysis for UAB vs CCHMC. Black dots
are genes, red dots are up-regulated while blue dots are down-regulated genes.
12
SMU Data Science Review, Vol. 3 [2020], No. 2, Art. 7
https://scholar.smu.edu/datasciencereview/vol3/iss2/7
Fig. 8. Venn diagram summarizing E18 vs E16 and UAB vs CCHMC DE gene counts.
We’ve found 12432 DE genes, 1256 were found when comparing UAB vs CCHMC,
82 when comparing E18 vs E16 and 16 genes were differentially expressed in both
comparisons.
of epithelial cells, flat thin cells with large surface area, called type I epithelial
cells, and taller cuboidal cells which are the AT2 cells. Each has a specific and
necessary function to perform. Type I cells are the actual site of gas exchange,
where gas molecules cross back and forth between the air in the alveolus and
the blood stream. The physics of gas diffusion requires that type I cells have
a surface that can be bathed by the surrounding gas and not obstructed by
overlying layers. When a person exhales the saccules and alveoli must remain
partially distended; collapse would bring opposing walls together and remove
the possibility to bathe the type I cell surfaces with gas. There are physical
forces that must be overcome to allow alveoli to remain distended even at the
low pressures that exist with expiration. These forces include surface tension
generated by the small amounts of water present in the alveolus. The surface
tension forces are sufficiently strong that if not sufficiently overcome, progressive
alveolar collapse will ensue and asphyxiate the person. The surface tension forces
are eliminated by pulmonary surfactant, which is manufactured, packaged, and
secreted by the AT2 cells.
AT2 cells mature into surfactant-producing cells after approximately 85% of
gestation is completed. The maturation process includes accelerating the pro-
duction of surfactant components several fold, development of the machinery
needed to package surfactant, and major increases in the capacity for surfac-
tant secretion and re-uptake. The components of surfactant, and the biology of
their production, has been worked out in detail. However, there is much less
understanding of other cellular processes controlling AT2 maturation.
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The contribution of this study for understanding development is the identi-
fication and definition of gene expression changes that occur during the process
of AT2 maturation. Changing gene expression during this developmental period
has been described in many different studies, particularly for individual genes
or small sets of related genes [1], but a comprehensive description of the overall
numbers of changing genes has not been described. This information is needed
in order to develop insight into what types of events occur in AT2 cells as they
mature for surfactant production.
7 Future Work
It is important that the findings of this study be strengthened and extended
by future work. The relevance of the gene profile identified here to AT2 cell
maturational pathways should be pursued beginning with pathway analysis, to
leverage this information into a better understanding of mechanisms of devel-
opment. For example, several studies indicate gestational timing differences for
AT2 maturation exist between males and females. Analysis of male and female
AT2 transcript signatures could help understand why male premature infants are
at greater risk of deficient surfactant production. Overall, future studies should
extend our findings into additional models of AT2 development and function
with the goal of identifying new approaches for treating and preventing RDS in
premature infants.
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